Table 3.

Markers of early left ventricular systolic dysfunction in univariate and multivariate analyses

	OR	95 % CI	p
Univariate analysis
Anterior vs. non-anterior wall STEMI	30.92	11.41–83.75	<0.0001
Heart failure prior to MI (I or II class according to the NYHA classification)	7.52	3.00–18.83	<0.0002
Body mass index (for a 10 kg/m2 increase)	2.76	1.22–6.23	<0.02
Hypertension	2.11	1.13–3.95	<0.02
Diabetes mellitus	2.03	0.96–4.29	0.066
BNP at discharge (for a 100 pg/mL increase)	1.89	1.48–2.43	<0.0001
TnImax (for a 10 ng/mL increase)	1.67	1.35–2.06	<0.0001
BNP at admission (for a 100 pg/mL increase)	1.61	1.14–2.28	<0.01
CRP 24 h after admission (for a 10 mg/L increase)	1.60	1.27–2.00	<0.0001
CRP at discharge (for a 10 mg/L increase)	1.55	1.24–1.93	<0.0002
Age (for a 10-year increase)	1.38	0.99–1.94	0.056
CRP at admission (for a 10 mg/L increase)	1.37	0.27–7.03	0.70
Leukocyte count 24 h after admission (for a 103 per μL increase)	1.30	1.14–1.48	<0.002
HbA1c (for a 1 % increase)	1.29	1.00–1.66	<0.05
Admission glycaemia (for a 1 mmol/L increase)	1.21	1.08–1.35	<0.001
CK-MBmax (for a 10 U/L increase)	1.08	1.04–1.13	<0.0002
Leukocyte count at admission (for a 103 per μL increase)	1.06	0.96–1.18	0.25
Multivariate analysis
Anterior vs. non-anterior wall STEMI	26.67	9.42–75.52	<0.001
TnImax (for a 10 ng/mL increase)	1.39	1.10–1.77	<0.007
CRP at discharge (for a 10 mg/L increase)	1.38	1.01–1.87	<0.04

Univariate analysis shows demographic, clinical, angiographic and biochemical parameters from Tables 1 and 2 with a p value ≤0.1 as well as CRP and leukocyte count independently of a p value

BNP B-type natriuretic peptide, CI confidence interval, CK-MB _max maximal activity of isoenzyme MB of creatine kinase, CRP C-reactive protein, MI myocardial infarction, NYHA New York Heart Association, OR odds ratio, STEMI ST-segment-elevation myocardial infarction, TnI _max maximal concentration of troponin I